An assessment of downward trends in neurodevelopmental disorders in the United States following removal of thimerosal from childhood vaccines
DAVID A. GEIER1 & MARK R. GEIER2
1 Graduate Student, Department of Biochemistry, George Washington University, Washington, DC, U.S.A.
2 The Genetic Centers of America, Silver Spring, MD, U.S.A.
Source of support: None
Potential confl ict of interest: David Geier has been a consultant in vaccine cases before the no-fault National Vaccine Injury Compensation Program (NVICP) and in civil litigation. Dr. Mark Geier has been an expert witness and a consultant in vaccine cases before the no-fault NVICP and in civil litigation
Summary
Background. The US is in the midst of an epidemic of neurodevelopmental disorders (NDs). Thimerosal is an ethylmercury-containing compound added to some childhood vaccines. Several previous epidemiological studies conducted in the US have associated Thimerosal-containing vaccine (TCV) administration with NDs.